Protein kinase a maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: Convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 3, 1998, Pages 1266-1273

  Wagner, Edward J ^a   Rønnekleiv, Oline K ^a   Kelly, Martin J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ESTROGEN; MORPHINE; MU OPIATE RECEPTOR AGONIST; PHORBOL DIBUTYRATE; STAUROSPORINE;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; GUINEA PIG; HYPERPOLARIZATION; HYPOTHALAMUS; NEUROSECRETORY CELL; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG TOLERANCE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; ESTROGENS; FEMALE; GUINEA PIGS; HYPOTHALAMUS; MORPHINE; NEUROSECRETORY SYSTEMS; PROTEIN KINASE C; RECEPTORS, OPIOID, MU;

EID: 0031808661     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Avidor-Reiss T, Bayewitch M, Levy R, Matus-Leibovitch N, Nevo I and Vogel Z (1995) Adenylylcyclase supersensitization in μ-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J Biol Chem 270: 29732-29738.
2. Bernstein MA and Welch SP (1995) Alterations in L-type calcium channels in the brain and spinal cord of acutely treated and morphine-tolerant mice. Brain Res 696:83-88.
3. Chavkin C and Goldstein A (1984) Opioid receptor reserve in normal and morphinetolerant guinea pig ileum myenteric plexus. Proc Natl Acad Sci USA 81:7253-7257.
4. Chen Y and Yul (1994) Differential regulation by cAMP-dependent protein kinase and protein kinase C of the μ opioid receptor coupling to a G protein-activated K(+) channel. J Biol Chem 269:7839-7842.
5. Christie MJ, Williams JT and North RA (1987) Cellular mechanisms of opioid tolerance: Studies in single brain neurons. Mol Pharmacol 32:633-638.
6. Deyo SN, Swift RM, Miller RJ and Fang VS (1980) Development of tolerance to the prolactin-releasing action of morphine and its modulation by hypothalamic dopamine. Endocrinology 106:1469-1474.
7. + channel expressed in Xenopus oocytes. Pflugers Arch 431:335-340.
8. Dostmann WRG, Taylor SS, Genieser H-G, Jastorff B, Doskeland SO and Ogreid D (1990) Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3′,5′-cyclic phosphorothioates. J Biol Chem 265:10484-10491.
9. Ellinwood WE, Ronnekleiv OK, Kelly MJ and Resko JA (1985) A new antiserum with conformational specificity for LHRH: Usefulness for radioimmunoassay and immunocytochemistry. Peptides 6:45-52.
10. Ferin M, Van Vugt D and Wardlaw S (1984) The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides. Recent Prog Horm Res 40:441-485.
11. +-ATPase in the choroid plexus: Regulation by serotonin/protein kinase C pathway. J Biol Chem 270:2427-2430.
12. Goldstein A and Naidu A (1989) Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol Pharmacol 36:265-272.
13. Goldstein A and Schulz R (1973) Morphine-tolerant longitudinal muscle strip from guinea pig ileum. Br J Pharmacol 48:655-666.
14. Guitart X and Nestler EJ (1993) Second messenger and protein phosphorylation mechanisms underlying opiate addiction: Studies in the rat locus coeruleus. Neurochem Res 18:5-13.
15. m GTPase and nucleotide-sensitive agonist binding. Neurosci Lett 100:221-226.
16. il, a GTP-binding protein in reconstituted lipid vesicles. Neurosci Lett 113:47-49.
17. Kapoor R and Willoughby JO (1990) Activation of opioid receptors in the mediobasal hypothalamus stimulates prolactin secretion in the conscious rat. J Neuroendocrinol 2:347-350.
18. Kluttz BW, Vrana KE, Dworkin SI and Childers SR (1995) Effects of morphine on forskolin-stimulated pro-enkephalin mRNA levels in rat striatum: A model for acute and chronic opioid actions in brain. Mol Brain Res 32:313-320.
19. Kobayashi E, Nakano H, Morimoto M and Tamaoki T (1989) Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 159:548-553.
20. Lagrange AH, Rønnekleiv OK and Kelly MJ (1995) Estradiol-17β and μ-opioid peptides rapidly hyperpolarize GnRH neurons: A cellular mechanism of negative feedback. Endocrinology 136:2341-2344.
21. Lagrange AH, Ronnekleiv OK and Kelly MJ (1997) Modulation of G protein-coupled receptors by an estogen receptor that activates protein kinase A. Mol Pharmacol 51:605-612.
22. Loose MD, Ronnekliev OK and Kelly MJ (1990) Membrane properties and response to opioids of identified dopamine neurons in the guinea pig hypothalamus. J Neurusci 10:3627-3634.
23. Loose MD and Kelly MJ (1990) Opioids act at μ-receptors to hyperpolarize arcuate neurons via an inwardly rectifying potassium conductance. Brain Res 513:15-23.
24. Meng J, Malanga CJ, Kong J-Q, Taylor DA and Fleming WW (1997) Hyperpolarizing effects of morphine, clonidine and 2-chloroadenosine in myenteric neurons associated with tolerance to morphine J Pharmacol Exp Ther 281:41-47.
25. Mestek A, Hurley JH, Bye LS, Campbell AD, Chen Y, Tian M, Liu J, Schulman H and Yu L (1995) The human μ opioid receptor: Modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J Neurosci 15:2396-2406.
26. Nakano H, Kobayashi E, Takahashi I, Tamaoki Y, Kuzuu Y and Iba H (1987) Staurosporine inhibits tyrosine-specific protein kinase activity of Rous sarcoma virus transforming protein p60. J Antibiot (Tokyo) 40:706-708.
27. Narita M, Feng Y, Makimura M, Hoskins B and Ho, IK (1994) A protein kinase inhibitor, H-7, inhibits the development of tolerance to opioid antinociception. Eur J Pharmacol 271:543-545.
28. Narita M, Mizoguchi H and Tseng LF (1995) Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered μ-opioid receptor agonist in the mouse. Eur J Pharmacol 280:R1-R3.
29. Narita M, Ohsawa M, Mizoguchi H, Kamei J and Tseng LF (1997) Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by μ-but not ∈-opioid receptor agonist in the mouse. Neuroscience 76:291-298.
30. Roerig SC (1995) Decreased spinal morphine/clonidine antinociceptive synergism in morphine-tolerant mice. Life Sci 56:PL115-PL122.
31. Ronnekleiv OK, Loose MD, Erickson KR and Kelly MJ (1990) A method for immunocytochemical identification of biocytin-labeled neurons following intracellular recording. Bio Techniques 9:432-438.
32. Ronnekleiv OK, Bosch MA, Cunningham MJ, Wagner EJ, Grandy DK and Kelly MJ (1996) Downregulation of μ-opioid receptor mRNA in the mediobasal hypothalamus of the female guinea pig following morphine treatment. Neurosci Lett 216: 129-132.
33. ++ dependent protein kinase. Biochem Biophys Res Commun 135:397-402.
34. Tokuyama S, Feng YZ, Wakabayashi H and HO, IK (1995) Possible involvement of protein kinases in physical dependence on opioids: Studies using protein kinase inhibitors, H-7 and H-8. Eur J Pharmacol 284:101-107.
35. 12 dopamine neurons with chronic morphine treatment. J Pharmacol Exp Ther 280:1057-1064.
36. Wang L, Medina VM, Rivera M and Gintzler AR (1996) Relevance of phosphorylation state to opioid responsiveness in opiate naive and tolerant/dependent tissue. Brain Res 723:61-69.
37. Wang Z, Bilsky EJ, Porreca F and Sadée W (1994) Constitutive μ opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci 54:PL339-PL350.
38. 2+/calmodulin-dependent protein kinase II. J Neurochem 56:294-298.
39. Zhang C, Bachoo M and Polosa C (1996) Long-term depression of a sympathetic ganglionic response to opioids by prolonged synaptic activity and by phorbol esters. Brain Res 710:1-10.
40. Zhang G, Lagrange AH, Ronnekleiv OK and Kelly MJ (1996) Tolerance of hypothalamic β-endorphin neurons to μ-opioid receptor activation following chronic morphine treatment. J Pharmacol Exp Ther 277:551-558.